Stocktoria
Sensei Biotherapeutics, Inc. FTH
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-02-04
Sensei Biotherapeutics, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating income | -$22.3M | -$32.6M | -$37.1M | -$50.2M | -$37.5M |
| Interest expense | $32,000 | $90,000 | $144,000 | $219,000 | $670,000 |
| Income tax | $0 | $0 | — | — | — |
| Net income | -$21.1M | -$30.2M | -$34.1M | -$48.6M | -$36.8M |
| EPS (diluted) | $-16.72 | $-24.01 | $-1.22 | $-1.58 | $-1.33 |
| Operating cash flow | -$20.5M | -$24.7M | -$32.0M | -$39.0M | -$30.3M |
| Free cash flow | -$20.5M | -$24.8M | -$32.2M | -$39.3M | -$32.3M |
| Cash & equivalents | $8.7M | $10.0M | $13.0M | $17.8M | $7.2M |
| Total assets | $22.9M | $45.4M | $74.4M | $118.4M | $153.2M |
| Total liabilities | $4.3M | $7.0M | $9.5M | $15.0M | $6.7M |
| Shareholders' equity | $18.6M | $38.4M | $64.9M | $103.4M | $146.5M |
Source: SEC EDGAR filings · CIK 0001829802 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.